Sign In

Dylan Beynon

Founder & CEO at Mindbloom - come work in psychedelic medicine!

Dylan Beynon is a dynamic individual who has founded three successful ventures with a passion for leveraging technology to enhance accessibility in critical areas like mental healthcare, civil justice, and local democracy.

Beynon is currently dedicated to revolutionizing lives and society by spearheading the introduction of psychedelic therapy in the United States, aiming to be a pioneer in this emerging field.

He completed his Bachelor of Science in Economics with a focus on Entrepreneurship and Decision Theory, along with a minor in Consumer Psychology at The Wharton School of the University of Pennsylvania, graduating with a full Trustee Scholarship.

Beynon's professional journey includes holding key roles such as Founder and CEO at Mindbloom, Co-founder and Chief Growth Officer at Mighty, Co-founder and Head of Marketing at Voter's Friend (which was later acquired by Democracy.com), and serving as a Growth Product Manager at Hotlist.

With a penchant for innovative solutions and an eye for pioneering opportunities, Beynon continues to make waves in the realm of technology-driven ventures and is on a quest for collaborators who share his trailblazing spirit.

Highlights

Aug 23 · linkedin

The FDA recently rejected MDMA therapy—for now.

This decision is a devastating blow to the 13 million Americans living with PTSD.

So, how did we get here? Why is Big Pharma sitting on the committee that blocked the approval of the most effective PTSD treatment in history? And why is the FDA ignoring studies they helped develop?

In my latest Psychedelic Optimist, I dive into the shady players behind this decision and explore what’s next for psychedelic medicine.

Jul 11 · linkedin

For my third Psychedelic Optimist newsletter, I dig into some of the wildest media narratives about ketamine therapy – and the hidden forces that shape them.

Check it out!

Dylan Beynon
Add to my network

Location

Austin, Texas, United States